Publications
5674 Results
- Journal / Conference
- Proc of the American Society of Clinical Oncology 19:492a(#1923)
- Year
- 2000
- Research Committee(s)
- Lung
- Study Number(s)
- S9705
Final results from Southwest Oncology Group trial (SWOG) 9705: A phase II trial of cisplatin, etoposide, and paclitaxel (PET) with G-CSF in untreated patients (PTS) with extensive small cell lung (SCLC).
- Journal / Conference
- Proc of the American Society of Clinical Oncology 19:490a(#1916)
- Year
- 2000
- Research Committee(s)
- Lung
- Study Number(s)
- SWOG-9504
Prolonged survival in pathologic stage IIIb non-small cell lung cancer (NSCLC) with concurrent chemoradiotherapy followed by consolidation docetaxel: a phase II study (S9504) of the Southwest Oncology Group (SWOG).
- Journal / Conference
- Proc of the American Society of Clinical Oncology 19:489a(#1913)
- Year
- 2000
- Research Committee(s)
- Lung
- Study Number(s)
- SWOG-9509
An economic analsis of Southwest Oncology Group trial S9509: Cisplatin/vinorelbine vs. carboplatin/paclitaxel for advanced nonsmall cell lung cancer
- Journal / Conference
- Proc of the American Society of Clinical Oncology 19:411a(#1624)
- Year
- 2000
- Research Committee(s)
- Head and Neck
- Study Number(s)
- SWOG-9059 (E-1392) (INT-0126)
A phase III comparison of standard radiation thereapy (RT) versus RT plus concurrent cisplatin (DDP) versus split-course RT plus concurrent DDP and 5-Fluorouracil (5FU) in patients with unresectable squamous cell head and neck cancer (SCHNC
- Journal / Conference
- Proc of the American Society of Clinical Oncology 19:159a(#617)
- Year
- 2000
- Research Committee(s)
- Brain
- Study Number(s)
- SWOG-9310 (INT-0143) (RTOG-93-10)
Radiation therapy (RT) alone vs. pre-RT chemotherapy (CTX) for the treatment of primary CNS lymphoma (PCNSL): age matched survival analysis of RTOG-83-15 and RTOG 93-10.
- Journal / Conference
- Proc of the American Society of Clinical Oncology 19:1a(#1)
- Year
- 2000
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- SWOG-9008 (INT-0116) (RTOG-9018) (NCCTG-90-41-51) (ECOG-6290) (CALGB-9195)
Postoperative combined radiation and chemotherapy improves disease-free survival (DFS) and overall survival (OS) in resected adenocarcinoma of the stomach and G.E. junction. results of Intergroup study INT-0116 (SWOG 9008)
- Journal / Conference
- Proc of the American Society of Clinical Oncology 19:487a(#1906)
- Year
- 2000
- Research Committee(s)
- Lung
- Study Number(s)
- SWOG-9416
Induction chemoradiation plus surgical resection is feasible and highly effective treatment for pancoast tumors: initial results of SWOG 9416 (Intergroup 0160) trial
- Journal / Conference
- Proc of the American Society of Clinical Oncology 19:240a(#931)
- Year
- 2000
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- SWOG-9415 (INT-0153) (CALGB-9498) (ECOG-S9415) (NCCTG-S9415)
Phase III randomized trial of bolus 5-FU/leucovorin/levamisole versus 5-FU continuous infusion/levamisole as adjuvant therapy for high risk colon cancer (SWOG 9415/INT-0153)
- Journal / Conference
- Proc of the American Society of Clinical Oncology 19:85a(#326)
- Year
- 2000
- Research Committee(s)
- Breast
- Study Number(s)
- S9625
Neoadjuvant doxorubicin, cyclophosphamide and G-CSF (AC+G) for locally advanced breast cancer (LABC), a Southwest Oncology Group phase II study
- Journal / Conference
- Journal of Urology 163(4):56Suppl(#242)
- Year
- 2000
- Research Committee(s)
- Genitourinary
- Study Number(s)
- SWOG-8894 (INT-0105) (EST-2889)